Authors: Melzer, M Brown, M Mullen, J O'Shea, S Chrystie, I Banatvala, J

Citation: M. Melzer et al., Undiagnosed symptomatic primary HIV infections in South London, J INFECTION, 42(4), 2001, pp. 297-298

Authors: Banatvala, J Van Damme, P Oehen, S

Citation: J. Banatvala et al., Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory, VACCINE, 19(7-8), 2000, pp. 877-885

Authors: McCormack, S Tilzey, A Carmichael, A Gotch, F Kepple, J Newberry, A Jones, G Lister, S Beddows, S Cheingsong, R Rees, A Babiker, A Banatvala, J Bruck, C Darbyshire, J Tyrrell, D Van Hoecke, C Weber, J

Citation: S. Mccormack et al., A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120(W61D) derived from dual tropic R5X4 HIV-1(ACH320), VACCINE, 18(13), 2000, pp. 1166-1177

Authors: O'Shea, S Chrystie, I Cranston, R Mullen, J Corbett, K Murphy, G Parry, JV De Ruiter, A Banatvala, J

Citation: S. O'Shea et al., Problems in the interpretation of HIV-1 viral load assays using commercialreagents, J MED VIROL, 61(2), 2000, pp. 187-194

Authors: Banatvala, J Van Damme, P Van Hattum, J

Citation: J. Banatvala et al., Boosters for hepatitis B, LANCET, 356(9226), 2000, pp. 337-338

Authors: Banatvala, J Kane, M Da Villa, G Esteban, R Franco, E Goudeau, A Grob, P Jilg, W Rizzetto, M Van Damme, P Van Hattum, J West, D Zuckerman, J

Citation: J. Banatvala et al., Are booster immunisations needed for lifelong hepatitis B immunity?, LANCET, 355(9203), 2000, pp. 561-565